KKR Group Holdings Corp. - Insider Non-Derivative Transactions at BridgeBio Pharma, Inc. (BBIO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 13, 2024, KKR Group Holdings Corp.'s relationship to BridgeBio Pharma, Inc. (BBIO) is TenPercentOwner, and currently has 25,260,971 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BBIO insiders.
Data Source: SEC.
KKR Group Holdings Corp. - Insider Non-Derivative Transactions at BBIO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 14, 2024 | Sell -- (Common Stock) | 5800000 | 25.75 | 25260971 |